{"id":"W2904773293","doi":"10.1111/ajt.15214","title":"The importance of drug safety and tolerability in the development of new immunosuppressive therapy for transplant recipients: The Transplant Therapeutics Consortium’s position statement","year":2018,"lang":"en","type":"article","venue":"American Journal of Transplantation","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Transplantation Society; CareDx; American Society of Transplant Surgeons; Bristol-Myers Squibb; Shire; CSL Behring; National Institute of Diabetes and Digestive and Kidney Diseases; American Society of Transplantation; Sanofi; Novartis; Astellas Pharma US; U.S. Food and Drug Administration","keywords":"Medicine; Tolerability; Position statement; Intensive care medicine; Safety profile; Immunosuppression; Drug; Renal transplant; Immunosuppressive drug; Adverse effect; Pharmacology; Transplantation; Internal medicine; Family medicine","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.1696904,0.001540441,0.003270973,0.001781428,0.005270206,0.01953627,0.00595668,0.04178372,0.001951048],"category_scores_gemma":[0.1424893,0.000941455,0.003321654,0.002502532,0.01405529,0.01197618,0.007664184,0.05657575,0.001622973],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01105524,"about_ca_system_score_gemma":0.07281575,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007697999,"about_ca_topic_score_gemma":0.01496617,"domain_scores_codex":[0.8859712,0.03553732,0.01882948,0.006015732,0.04945775,0.004188595],"domain_scores_gemma":[0.6392808,0.1981684,0.03454205,0.008056663,0.08662646,0.03332564],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000416237,0.0004123383,0.004315877,0.001678714,0.0003323187,0.0008722145,0.00144115,0.001322737,0.002153685,0.06383815,0.6598703,0.2633462],"study_design_scores_gemma":[0.0003341485,0.001043467,0.005203502,0.004552318,0.000419442,0.001321429,0.0005987143,0.002015348,0.002657681,0.02916786,0.9523333,0.000352771],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.001014212,0.02589045,0.001823056,0.9482786,0.0173673,0.0000811812,0.00008135395,0.00004461282,0.005419161],"genre_scores_gemma":[0.03658375,0.03803665,0.01276421,0.8162873,0.08771129,0.0003072382,0.0002854415,0.000180652,0.00784352],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.1696904,"threshold_uncertainty_score":0.8974191,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02342223440004979,"score_gpt":0.322924756459961,"score_spread":0.2995025220599112,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}